Biosyngen Funding: $86M Raised, Venture - Series Unknown
Biosyngen is based in Singapore, Singapore. It has raised $86M in total funding. Latest round: Venture - Series Unknown.
Biosyngen funding overview
Biosyngen is based in Singapore, Singapore. Biosyngen has raised $86M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Venture - Series Unknown announced in October 2021. The round record for Biosyngen runs through 2021; nothing later has been disclosed. Investors on record include Science City (Guangzhou) Investment Group Co., Ltd..
Biosyngen at a glance
Total raised
$86M
Latest round
Venture - Series Unknown
Latest round date
October 2021
Headquarters
Singapore, Singapore
Notable investors
Science City (Guangzhou) Investment Group Co., Ltd.
Frequently asked about Biosyngen funding
How much has Biosyngen raised?
Biosyngen has raised $86M in total disclosed funding across the rounds on record.
Who has invested in Biosyngen?
Science City (Guangzhou) Investment Group Co., Ltd. are named among the investors backing Biosyngen.
What was the latest Biosyngen funding round?
The most recent disclosed round is a Venture - Series Unknown, announced in October 2021.
Where is Biosyngen based?
Biosyngen is based in Singapore, Singapore.
When did Biosyngen last raise?
The last disclosed Biosyngen round closed in October 2021 at Venture - Series Unknown.
Biosyngen totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Singapore below to benchmark round size and investor mix.
